SCHEMBL4780332

SCHEMBL4780332

Fc1cccc(N2CC3C(C2)C3N(Cc2ccccc2)Cc2ccccc2)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.38
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
TDP1 Q9NUW8 2/20 0.35
TRPA1 O75762 1/20 0.35
UBE2M P61081 1/20 0.33
DCUN1D1 Q96GG9 1/20 0.33
KMT2A Q03164 2/20 0.33
NOTUM Q6P988 2/20 0.33
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
CACNA1G O43497 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1I Q9P0X4 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4778369 0.90 NOTUM (0.40) CHRM4KDM4EALDH1A1SMN1; SMN2DRD2
SCHEMBL4774338 0.89 DRD2 (0.32) CHRM4KDM4EALDH1A1SMN1; SMN2DRD2
SCHEMBL4779536 0.89 DRD2 (0.32) CHRM4KDM4EALDH1A1SMN1; SMN2DRD2
SCHEMBL4779453 0.87 NOTUM (0.46) CHRM4KDM4EALDH1A1DRD2DRD3
SCHEMBL4774390 0.85 KDM4E (0.40) KDM4EALDH1A1SMN1; SMN2DRD2DRD3
SCHEMBL4780326 0.82 CHRM4 (0.40) CHRM4KDM4EALDH1A1SMN1; SMN2DRD2
SCHEMBL4321609 0.80 GRM5 (0.42) CHRM4ALDH1A1DRD2DRD3KMT2A
SCHEMBL4779333 0.80 CHRM4 (0.39) CHRM4UBE2MDCUN1D1
SCHEMBL4781028 0.78 KDM4E (0.43) KDM4EALDH1A1KMT2ANOTUMCYP2C9
SCHEMBL4779787 0.78 FFAR4 (0.38) UBE2MDCUN1D1KMT2APOLBCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed